5.60% -0.2269

Iovance Biotherapeutics Inc (IOVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt IOVA? Forum Prognose Aktiensplit

Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	12.52% 67.45	59.95	49.32	58.55	31.11
Cost Of Revenue	32.10% 38.48	56.66	49.74	39.82	31.37
Gross Profit	781.33% 28.98	3.288	-0.417	18.73	-0.262
Operating Expenses	5.82% 123.88	117.06	120.80	107.80	101.65
Benefits Costs and Expenses	5.02% 161.11	169.62	167.32	143.62	129.66
Costs And Expenses	6.54% 162.36	173.73	170.54	147.62	133.02
Depreciation and Amortization	9.007	-	-	-	-
Operating Income/Loss	16.59% -94.90	-113.77	-121.22	-89.07	-101.91
Income/Loss From Continuing Operations Before Tax	14.60% -93.66	-109.67	-118.00	-85.06	-98.56
Income Tax Expense/Benefit, Deferred	220.98% -2.405	1.988	-1.838	-1.521	-1.458
Income Tax Expense/Benefit	220.98% -2.405	1.988	-1.838	-1.52	-1.458
Income/Loss From Continuing Operations After Tax	18.27% -91.25	-111.66	-116.16	-83.54	-97.10
Net Income/Loss	18.27% -91.25	-111.66	-116.16	-83.54	-97.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8.83% 0.364	0.3345	0.3229	0.3033	0.2848
Basic Earnings Per Share	24.24% -0.25	-0.33	-0.36	-0.28	-0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%